Clinical Trial Update: Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining amivantamab with hyaluronidase or cetuximab for advanced cutaneous squamous cell carcinoma in people with weakened immun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Amivantamab (amivantamab)
• Cetuximab (cetuximab)
• Hyaluronidase (hyaluronidase)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Locally Recurrent Skin Squamous Cell Carcinoma, Metastatic Skin Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING